Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study
Files
Publication date
2024-03-15
Authors
Poukka, Eero
Roekel, Caren van
Turunen, Topi
Baum, Ulrike
Kramer, Rolf
Begier, Elizabeth
Presser, Lance D.
Teirlinck, Anne
Heikkinen, Terho
Knol, Mirjam
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Several immunization products are currently being developed against respiratory syncytial virus (RSV) for children, pregnant females, and older adults, and some products have already received authorization. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct postmarketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunization product effectiveness against RSV-specific and nonspecific outcomes. To conduct a study on the basis of this generic protocol, the researchers can use any relevant databases or healthcare registers that are available at the study site.
Keywords
maternal immunization, monoclonal antibody, respiratory syncytial virus, RSV, vaccine, Taverne, General Medicine
Citation
Poukka, E, Roekel, C V, Turunen, T, Baum, U, Kramer, R, Begier, E, Presser, L D, Teirlinck, A C, Heikkinen, T, Knol, M, Nohynek, H, Bont, L & PROMISE investigators 2024, 'Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus : Generic Protocol for Register-Based Cohort Study', Journal of Infectious Diseases, vol. 229, pp. S84-S91. https://doi.org/10.1093/infdis/jiad484